You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Smoldering Waldenstrom Macroglobulinemia(WM)

Showing 1 - 25 of 345
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

Not yet recruiting
  • Cancer Prevention
  • +5 more
  • Prolonged Fasting Intervention
  • EDUCATION CONTROL
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 28, 2022

Questionnaire and Tissue Banking For Multiple Myeloma,

Active, not recruiting
  • Multiple Myeloma
  • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 15, 2022

    Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Zanubrutinib, Bendamustine and Rituximab
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jun 13, 2023

    Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Waldenstrom Macroglobulinemia (WM)
    • Shingrix vaccine
    • Rochester, New York
      University of Rochester
    Jan 9, 2023

    Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

    Active, not recruiting
    Has Results
    • Waldenstrom Macroglobulinemia
    • Chiba, Japan
    • +8 more
    Jan 27, 2023

    Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • Changchun, China
    • +5 more
    Jan 27, 2023

    Waldenstrom Macroglobulinemia Trial in Hackensack (Carfilzomib, Rituximab, Dexamethasone)

    Completed
    Has Results
    • Waldenstrom Macroglobulinemia
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Mar 18, 2022

    Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 1, 2022

    Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • MYD88 Gene Mutation
    • Boston, Massachusetts
    • +1 more
    Apr 1, 2022

    Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • DASATINIB
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 22, 2022

    Zanubrutinib in Waldenström's Macroglobulinemia (ARIADNE)

    Recruiting
    • Waldenström's Macroglobulinemia
    • Salzburg, Austria
    • +1 more
    May 2, 2022

    Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

    Completed
    Has Results
    • Waldenström's Macroglobulinemia (WM)
    • Beijing, Beijing, China
    • +10 more
    Mar 7, 2022

    Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

    Not yet recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +5 more
    • Routine care as per site standard.
    • (no location specified)
    Sep 15, 2023

    Waldenström Macroglobulinemia (WM) Trial in Worldwide (Acalabrutinib (ACP-196))

    Active, not recruiting
    Has Results
    • Waldenström Macroglobulinemia (WM)
    • Acalabrutinib (ACP-196)
    • Santa Barbara, California
    • +37 more
    Mar 17, 2022

    MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • +8 more
      • Boston, Massachusetts
      • +6 more
      Apr 14, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • +7 more
      • Manchester, United Kingdom
      • +2 more
      Aug 11, 2022

      IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

      Recruiting
      • IgA Monoclonal Gammopathy
      • +8 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Oct 18, 2021

      Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

      Completed
      • Waldenström's Macroglobulinemia
      • Phoenix, Arizona
      • +79 more
      Jul 6, 2022

      Waldenstrom's Macroglobulinemia Trial in Boston (Bortezomib, Rituximab)

      Completed
      Has Results
      • Waldenstrom's Macroglobulinemia
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Oct 6, 2020

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • +6 more
      • Duarte, California
      • +10 more
      Jul 14, 2022

      Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

      Recruiting
      • Waldenstrom Macroglobulinemia
      • +8 more
      • Iopofosine I 131 single dose
      • +2 more
      • Redlands, California
      • +42 more
      Dec 30, 2022

      Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • +2 more
      • (no location specified)
      Jul 18, 2023

      Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

      Suspended
      • Lymphoplasmacytic Lymphoma
      • Waldenstrom Macroglobulinemia
      • Centralia, Illinois
      • +73 more
      Jul 27, 2022

      Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

      Completed
      Has Results
      • Waldenstrom's Macroglobulinemia
      • Boston, Massachusetts
      • +1 more
      Dec 5, 2022

      Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • B-Cell Lymphoproliferative Disorder
      • Boston, Massachusetts
      • +2 more
      Feb 18, 2023